Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Issued (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Shares Issued data on record, last reported at $985000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 89.54% year-over-year to $985000.0; the TTM value through Dec 2025 reached $4.3 million, down 58.23%, while the annual FY2025 figure was $4.3 million, 58.23% down from the prior year.
  • Shares Issued reached $985000.0 in Q4 2025 per COLL's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $11.2 million in Q4 2021 and bottomed at -$7.5 million in Q3 2021.
  • Average Shares Issued over 5 years is $2.5 million, with a median of $1.4 million recorded in 2025.
  • Peak YoY movement for Shares Issued: soared 6018.58% in 2021, then crashed 3366.9% in 2023.
  • A 5-year view of Shares Issued shows it stood at $11.2 million in 2021, then plummeted by 38.71% to $6.9 million in 2022, then increased by 19.2% to $8.2 million in 2023, then rose by 15.13% to $9.4 million in 2024, then tumbled by 89.54% to $985000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $985000.0 in Q4 2025, $1.4 million in Q3 2025, and $308000.0 in Q2 2025.